Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OKSI (Universitas Negeri Semarang)
- Development stage
- Phase 3
- Lead developer
- Universitas Negeri Semarang
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
OKSI is a botanical combination extract developed by Universitas Negeri Semarang, Indonesia, specifically formulated to mitigate exercise-induced oxidative stress. The product contains a mixture of 400 mg of Garcinia mangostana (mangosteen) rind extract and 200 mg of Solanum lycopersicum fructus (tomato) extract. It leverages the antioxidant properties of bioactive compounds such as xanthones and anthocyanins from mangosteen, alongside lycopene and other antioxidants from tomato. OKSI is primarily intended for sedentary individuals to reduce biomarkers of oxidative damage and cardiac stress, specifically targeting levels of malondialdehyde (MDA) and high-sensitivity Cardiac-Troponin I (hs-cTnI) following physical exertion. It is registered as a traditional medicine in Indonesia.
- Brand names
- OKSI
- Other names
- Garcinia mangostana rind and Solanum lycopersicum fructus extractGarcinia-mangostana-L-rind and Solanum-Lycopersicum-Fructus mixture-extractmangosteen and tomato extract
Beyond the preview
Go deeper on OKSI (Universitas Negeri Semarang).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OKSI (Universitas Negeri Semarang).